Objective: Chronic kidney disease is characterized by a state of chronic inflammation which is associated with poor cardiovascular disease outcomes. The study determined the prevalence of elevated neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as surrogate markers of inflammation and their association with some cardiovascular risk factors among pre-dialysis CKD patients. Method: This was a cross-sectional study to determine and compare the prevalence of elevated NLR and PLR. The correlation between these surrogate inflammatory markers and some cardiovascular risk factors was determined. Data were analyzed using SPSS version 21 software. P-value of < 0.05 was taken as significant. Results: This study involved 51 pre-dialysis CKD patients and 51 controls with mean ages of 50.96±11.42 years and 48.31±9.83 years, respectively. The prevalence of elevated NLR was significantly higher in the CKD group (35.3% vs13.7%; P=0.010). In the CKD group, there was significant negative correlation between NLR and eGFR (r= -0.393; P=0.004), hemoglobin concentration (r= -0.543; P=<0.001) and HDL (r= -0.292; P=0.037). There was significant positive correlation between NLR and PLR (r=0.669; P=<0.001), TC:HDL (r=0.334; P=0.017), AIP(r=0.289; P=0.042) and LDL:HDL (r=0.320; P=0.020). There was significant positive correlation between PLR, NLR (r=0.695; P=<0.001) and AIP (r=0.283; P=0.047). There was significant negative correlation between PLR and estimated GFR (r=- 0.448; P=0.001), hemoglobin concentration (r= -0.596; P=<0.001), serum albumin (r= -0.388; P=0.005), serum HDL-C (r= -0.387; P= 0.005). Conclusion: NLR and PLR were significantly higher in pre-dialysis CKD patients and were associated with cardiovascular risk. They should be routinely used to identify those with high cardiovascular risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.